Bell's Palsy as a Late Neurologic Manifestation of COVID-19 Infection.
bell’s palsy
covid-19 infection
facial weakness
neurologic manifestation
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
14 Mar 2021
14 Mar 2021
Historique:
entrez:
19
4
2021
pubmed:
20
4
2021
medline:
20
4
2021
Statut:
epublish
Résumé
Bell's palsy is acute peripheral facial nerve palsy; its cause is often unknown but it can be triggered by acute viral infection. Coronavirus disease 2019 (COVID-19) infection commonly presents with respiratory symptoms, but neurologic complications have been reported. A few studies have reported the occurrence of facial nerve palsy during the COVID-19 pandemic. We present a case of Bell's palsy in a 36-year-old man with COVID-19 infection and a past medical history of nephrolithiasis. He presented to the emergency room with a day history of sudden right facial weakness and difficulty closing his right eye four weeks following a diagnosis of COVID-19 infection. Physical examination revealed right lower motor neuron facial nerve palsy (House-Brackmann grade IV). Serologic screen for Lyme disease, human immunodeficiency virus (HIV), and herpes simplex virus (HSV) 1 and 2 were negative for acute infection; however, neuroimaging with MRI confirmed Bell's palsy. He made remarkable improvement following treatment with a course of valacyclovir and methylprednisolone. This case adds to the growing body of literature on neurological complications that should be considered when managing patients with COVID-19 infection.
Identifiants
pubmed: 33868845
doi: 10.7759/cureus.13881
pmc: PMC8043567
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e13881Informations de copyright
Copyright © 2021, Oke et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Neurology. 2020 Aug 25;95(8):364-367
pubmed: 32439822
J Neurol. 2020 Jul;267(7):1896-1905
pubmed: 30923934
BMJ. 2009 Sep 07;339:b3354
pubmed: 19736282
J Virol. 2018 Aug 16;92(17):
pubmed: 29925652
Cell Mol Immunol. 2020 Jun;17(6):613-620
pubmed: 32203189
Neurology. 2020 Aug 4;95(5):e601-e605
pubmed: 32303650
J Neurovirol. 2020 Dec;26(6):941-944
pubmed: 33006717
Brain Dev. 2021 Feb;43(2):357-359
pubmed: 32950319
BMJ Case Rep. 2020 Aug 11;13(8):
pubmed: 32784234
Am J Case Rep. 2020 Oct 31;21:e927956
pubmed: 33128540
Brain Behav. 2020 Nov;10(11):e01839
pubmed: 32935915
Acta Otolaryngol Suppl. 2002;(549):4-30
pubmed: 12482166
ACS Chem Neurosci. 2020 Apr 1;11(7):995-998
pubmed: 32167747
Med Sci Monit. 2014 Jan 20;20:83-90
pubmed: 24441932
Brain Behav. 2021 Jan;11(1):e01939
pubmed: 33159420
J Laryngol Otol. 2020 Oct 01;:1-4
pubmed: 32998780
Lancet Neurol. 2020 May;19(5):383-384
pubmed: 32246917